Myriad Genetics (MYGN) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $5.92 -4.21%
Revenue Growth %: -3.3%
Financial Fact:
Net income: -1.2M
Today's EPS Names:
PEBK, DIT, AMC, More
Revenue Growth %: -3.3%
Financial Fact:
Net income: -1.2M
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q1 EPS of $0.41, $0.06 better than the analyst estimate of $0.35. Revenue for the quarter came in at $183.5 million versus the consensus estimate of $177.89 million.
Myriad Genetics sees FY2015 EPS of $1.60-$1.65, versus the consensus of $1.64. Myriad Genetics sees FY2015 revenue of $750-770 million, versus the consensus of $758.3 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q2 EPS by 6c, Offers Guidance
- Crown Holdings (CCK) Tops Q2 EPS by 33c; offers outlook
- Zions Bancorp (ZION) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
